HUP0003803A2 - Flunarizin alkalmazása zöldhályog helyi kezelésére alkalmas gyógyszerkészítmény előállítására - Google Patents

Flunarizin alkalmazása zöldhályog helyi kezelésére alkalmas gyógyszerkészítmény előállítására

Info

Publication number
HUP0003803A2
HUP0003803A2 HU0003803A HUP0003803A HUP0003803A2 HU P0003803 A2 HUP0003803 A2 HU P0003803A2 HU 0003803 A HU0003803 A HU 0003803A HU P0003803 A HUP0003803 A HU P0003803A HU P0003803 A2 HUP0003803 A2 HU P0003803A2
Authority
HU
Hungary
Prior art keywords
flunarizine
glaucoma
pharmaceutical compositions
compositions useful
producing pharmaceutical
Prior art date
Application number
HU0003803A
Other languages
English (en)
Inventor
Giuseppe Lisi
Original Assignee
Laboratoire Medidom S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoire Medidom S.A. filed Critical Laboratoire Medidom S.A.
Publication of HUP0003803A2 publication Critical patent/HUP0003803A2/hu
Publication of HUP0003803A3 publication Critical patent/HUP0003803A3/hu
Publication of HU227940B1 publication Critical patent/HU227940B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A találmány tárgya a flunarizin, egy agyi és perifériásértágító szerként ismert és alkalmazott kálciumcsatorna-blokkolóalkalmazása a zöldhályog helyi adagolással történő kezelésére alkalmasgyógyszerkészítmény előállítására. A találmány a flunarizin és béta-blokkolók, mint a timolol keverékét tartalmazó zöldhályog-elleneskészítményekre is vonatkozik. Ó
HU0003803A 1997-10-10 1998-10-06 Flunarizin alkalmazása zöldhályog helyi kezelésére alkalmas gyógyszerkészítmény elõállítására HU227940B1 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000613A IT1295423B1 (it) 1997-10-10 1997-10-10 Uso della flunarizina nella terapia topica del glaucoma
PCT/IT1998/000266 WO1999018963A1 (en) 1997-10-10 1998-10-06 Use of flunarizine for the topical treatment of glaucoma

Publications (3)

Publication Number Publication Date
HUP0003803A2 true HUP0003803A2 (hu) 2001-05-28
HUP0003803A3 HUP0003803A3 (en) 2001-12-28
HU227940B1 HU227940B1 (hu) 2012-06-28

Family

ID=11405290

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003803A HU227940B1 (hu) 1997-10-10 1998-10-06 Flunarizin alkalmazása zöldhályog helyi kezelésére alkalmas gyógyszerkészítmény elõállítására

Country Status (16)

Country Link
US (1) US6380198B1 (hu)
EP (1) EP1021184B1 (hu)
JP (1) JP4475802B2 (hu)
AT (1) ATE289198T1 (hu)
AU (1) AU734137B2 (hu)
BR (1) BR9813855A (hu)
CA (1) CA2306371C (hu)
CZ (1) CZ294314B6 (hu)
DE (1) DE69829062T2 (hu)
ES (1) ES2237852T3 (hu)
HU (1) HU227940B1 (hu)
IT (1) IT1295423B1 (hu)
PL (1) PL192217B1 (hu)
PT (1) PT1021184E (hu)
SK (1) SK285200B6 (hu)
WO (1) WO1999018963A1 (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2398900A1 (en) * 2000-01-31 2001-08-09 Santen Pharmaceutical Co., Ltd. Therapeutic agents for opthalmopathy
CA2492989C (en) * 2002-07-23 2012-11-20 Novartis Ag Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
KR101277520B1 (ko) * 2004-09-10 2013-06-21 뉴론 파마슈티칼즈 에스. 피. 에이. （할로벤질옥시）벤질아미노－프로판아미드를 포함하는 선택적 나트륨 및／또는 칼슘 채널 조절제로서 유용한 약제학적 조성물
CA2629065C (en) * 2005-12-22 2013-08-06 Newron Pharmaceuticals S.P.A. 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators
WO2007076358A1 (en) * 2005-12-23 2007-07-05 Alcon, Inc. PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
PE20071221A1 (es) 2006-04-11 2007-12-14 Arena Pharm Inc Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
DK2723710T3 (en) 2011-06-27 2016-11-21 Newron Pharm Spa Flour ready arylalkylaminocarboxamidderivater

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023082A1 (en) * 1992-05-13 1993-11-25 Alcon Laboratories, Inc. Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents

Also Published As

Publication number Publication date
ES2237852T3 (es) 2005-08-01
SK4992000A3 (en) 2000-12-11
ITRM970613A1 (it) 1999-04-10
HU227940B1 (hu) 2012-06-28
JP4475802B2 (ja) 2010-06-09
AU9643398A (en) 1999-05-03
JP2001519394A (ja) 2001-10-23
AU734137B2 (en) 2001-06-07
CA2306371A1 (en) 1999-04-22
EP1021184B1 (en) 2005-02-16
PL192217B1 (pl) 2006-09-29
SK285200B6 (sk) 2006-08-03
BR9813855A (pt) 2000-09-19
WO1999018963A1 (en) 1999-04-22
IT1295423B1 (it) 1999-05-12
DE69829062D1 (de) 2005-03-24
ATE289198T1 (de) 2005-03-15
HUP0003803A3 (en) 2001-12-28
DE69829062T2 (de) 2006-02-09
CZ20001213A3 (cs) 2000-07-12
PT1021184E (pt) 2005-06-30
EP1021184A1 (en) 2000-07-26
CA2306371C (en) 2008-12-02
PL339453A1 (en) 2000-12-18
CZ294314B6 (cs) 2004-11-10
US6380198B1 (en) 2002-04-30

Similar Documents

Publication Publication Date Title
HUP0300030A2 (en) Bupropion metabolites and methods of their synthesis and use and pharmaceutical compositions containing them and and their use
CA2258548A1 (en) Phenylamino-substituted tricyclic derivatives for treatment of hyperproliferative diseases
HUP0300826A2 (hu) Egy epotilon-analóg polimorfjai, eljárás az elżállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0203198A2 (hu) Tramadolvegyület és görcsoldó hatóanyagot tartalmazó gyógyászati készítmény, eljárás az előállítására és alkalmazása
BG104727A (en) Pharmaceutical composition of topiramate
BR9506924A (pt) Composição farmacêutica sublingual ou bucal e utilização do trans-5-cloro-2-metil-2,3,3a, 12b-tetraidro-1h-dibenz(2,3:6,7) oxepino(4,5-c)pirrol
IL112622A0 (en) Camptothecin derivatives, their preparation and pharmaceutical compositions containing them
MX9300407A (es) Derivados azabiciclicos usados en la fabricacion de medicamentos, composiciones que los contienen y procedimiento para su preparacion.
UA34416C2 (uk) Похідні хроману, активні стосовно 5-нт рецептора, спосіб їх одержання та проміжні сполуки
HUP0302635A2 (hu) Valpronsav foszfolipidszármazékai és ezek keveréke
AU7496894A (en) Antiglucocorticoid steroids for the treatment of anxiety disorders
HUP0003803A2 (hu) Flunarizin alkalmazása zöldhályog helyi kezelésére alkalmas gyógyszerkészítmény előállítására
AU1306795A (en) Anticonvulsant pseudofructopyranose sulfamates
MX9603606A (es) N-metil-n-[(1s)-1-fenil-2-((3s)-3-hidroxipirrolidin-1-il) etil]-2,2-difenil-acetamida.
WO2002060435A8 (fr) Cryptotanshinone permettant de prevenir et d'attenuer la maladie d'alzheimer
CA2282279A1 (en) Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
AU623805B2 (en) New use of anti-progestomimetic compounds
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
HUP9800512A2 (hu) Moenomicin csoportba tartozó antibiotikumok bizmutsói, eljárás előállításukra, ezek alkalmazása és ezeket tartalmazó gyógyszerkészítmények
MY114282A (en) Anthracycline derivatives
MXPA02000242A (es) Analogos de 2-aminoindano.
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
IL111805A0 (en) Pharmaceutical compositions comprising dimeticone for the treatment of aphthae
AU6826700A (en) Ceramide analogs, process for their preparation and their use as antitumor agents
MX9702253A (es) Nuevos estrenos para inducir efectos hipotalamicos

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees